Roodink I - Search Results

1

Plexin D1 expression is induced on tumor vasculature and tumor cells: a novel target for diagnosis and therapy?

Roodink I, Raats J, van der Zwaag B, Verrijp K, Kusters B, van Bokhoven H, Linkels M, de Waal RM, Leenders WP. Roodink I, et al. Cancer Res. 2005 Sep 15;65(18):8317-23. doi: 10.1158/0008-5472.CAN-04-4366. Cancer Res. 2005. PMID: 16166308 Free article.

2

Development of the tumor vascular bed in response to hypoxia-induced VEGF-A differs from that in tumors with constitutive VEGF-A expression.

Roodink I, van der Laak J, Kusters B, Wesseling P, Verrijp K, de Waal R, Leenders W. Roodink I, et al. Int J Cancer. 2006 Nov 1;119(9):2054-62. doi: 10.1002/ijc.22072. Int J Cancer. 2006. PMID: 16804907

3

Semaphorin 3E expression correlates inversely with Plexin D1 during tumor progression.

Roodink I, Kats G, van Kempen L, Grunberg M, Maass C, Verrijp K, Raats J, Leenders W. Roodink I, et al. Am J Pathol. 2008 Dec;173(6):1873-81. doi: 10.2353/ajpath.2008.080136. Epub 2008 Oct 30. Am J Pathol. 2008. PMID: 18974298 Free PMC article.

4

Plexin D1 is ubiquitously expressed on tumor vessels and tumor cells in solid malignancies.

Roodink I, Verrijp K, Raats J, Leenders WP. Roodink I, et al. BMC Cancer. 2009 Aug 25;9:297. doi: 10.1186/1471-2407-9-297. BMC Cancer. 2009. PMID: 19703316 Free PMC article.

5

Isolation of targeting nanobodies against co-opted tumor vasculature.

Roodink I, Franssen M, Zuidscherwoude M, Verrijp K, van der Donk T, Raats J, Leenders WP. Roodink I, et al. Lab Invest. 2010 Jan;90(1):61-7. doi: 10.1038/labinvest.2009.107. Epub 2009 Oct 12. Lab Invest. 2010. PMID: 19823171 Free article.

6

Targeted therapies of cancer: angiogenesis inhibition seems not enough.

Roodink I, Leenders WP. Roodink I, et al. Cancer Lett. 2010 Dec 18;299(1):1-10. doi: 10.1016/j.canlet.2010.09.004. Cancer Lett. 2010. PMID: 20889254 Review.

7

Micronodular transformation as a novel mechanism of VEGF-A-induced metastasis.

Küsters B, Kats G, Roodink I, Verrijp K, Wesseling P, Ruiter DJ, de Waal RM, Leenders WP. Küsters B, et al. Among authors: roodink i. Oncogene. 2007 Aug 23;26(39):5808-15. doi: 10.1038/sj.onc.1210360. Epub 2007 Mar 12. Oncogene. 2007. PMID: 17353901

8

In vivo phage display screening for tumor vascular targets in glioblastoma identifies a llama nanobody against dynactin-1-p150Glued.

van Lith SA, Roodink I, Verhoeff JJ, Mäkinen PI, Lappalainen JP, Ylä-Herttuala S, Raats J, van Wijk E, Roepman R, Letteboer SJ, Verrijp K, Leenders WP. van Lith SA, et al. Among authors: roodink i. Oncotarget. 2016 Nov 1;7(44):71594-71607. doi: 10.18632/oncotarget.12261. Oncotarget. 2016. PMID: 27689404 Free PMC article.

9

Circulating tumour tissue fragments in patients with pulmonary metastasis of clear cell renal cell carcinoma.

Kats-Ugurlu G, Roodink I, de Weijert M, Tiemessen D, Maass C, Verrijp K, van der Laak J, de Waal R, Mulders P, Oosterwijk E, Leenders W. Kats-Ugurlu G, et al. Among authors: roodink i. J Pathol. 2009 Nov;219(3):287-93. doi: 10.1002/path.2613. J Pathol. 2009. PMID: 19731255

10

Broad Epitope Coverage of Therapeutic Multi-Antibody Combinations Targeting SARS-CoV-2 Boosts In Vivo Protection and Neutralization Potency to Corner an Immune-Evading Virus.

Roodink I, van Erp M, Li A, Potter S, van Duijnhoven SMJ, Smits M, Kuipers AJ, Kazemier B, Berkeveld B, van Geffen E, Vries BS, Rijbroek D, Boers B, Meurs S, Hemrika W, Thom A, Duplantis BN, Romijn RA, Houser JS, Bath JL, Abdiche YN. Roodink I, et al. Biomedicines. 2024 Mar 13;12(3):642. doi: 10.3390/biomedicines12030642. Biomedicines. 2024. PMID: 38540255 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters